Skip to content

Effects of controlled intravenous analgesia without background dose of oxycodone and fentanyl on analgesia and depression after laparoscopic hysteromyomectomy

Background dose-free controlled intravenous analgesia of oxycodone and fentanyl on analgesia after laparoscopic hysteromyoma resection: a randomized controlled study

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100051924
Enrollment
Unknown
Registered
2021-10-09
Start date
2022-01-01
Completion date
Unknown
Last updated
2022-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative pain

Interventions

Experimental group:Oxycodone for pain relief
Control group:Fentanyl for pain relief

Sponsors

Qilu Hospital of Shandong University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Patients aged >=18 years who underwent elective laparoscopic hysteromyectomy for uterine fibroids in Qilu Hospital; 2.ASA I-II level; 3.The patient provides written informed consent; 4.The patient can cooperate to obtain the result measurement; 5.The patient agrees to participate.

Exclusion criteria

Exclusion criteria: 1.Patients who are pregnant or breastfeeding; 2.The patient suffers from dementia or severe mental illness; 3.The patient has a history of oxycodone allergy; 4.Patients with respiratory depression, paralytic ileus, etc. who should not use oxycodone hydrochloride; 5.Patients who have performed additional surgical operations or abandoned the original surgical arrangement; 6.The patient is participating in other clinical trials; is taking opioids and/or antidepressants; 7.Patients with BMI>=30.

Design outcomes

Primary

MeasureTime frame
Visual Analogue Scale;

Secondary

MeasureTime frame
Ramsay sedation score;Self-rating depression scale;

Countries

China

Contacts

Public ContactDong Ping

Qilu Hospital of Shandong University

dongpingdoctor@163.com+86 531 82165727

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 5, 2026